| |  Mangalam Drugs & Organics Ltd. |
Country: India
Rupam Building, 3rd Floor,
239, P. D. Mello Road,
Near G.P.O. Mumbai 400001
(INDIA)
| | Phone: | (+91) 22 22616200 | | Phone 2: | (+91) 22 22616300 | | Phone 3: | (+91) 22 22618787 | | FAX: | (+91) 22 22619090 | | E-Mail: | E-Mail this Supplier |
Contact: Chetan Sarda
http://www.mangalamdrugs.com
|
|
Mangalam Drugs & Organics Limited commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and Intermediates at VAPI – Gujarat in 1977. It has a multi-product manufacturing facility on two locations, and an in-house Research & Development laboratory recognized by the Department of Scientific & Industrial Research, Delhi Govt. of India (DSIR).Over the last four decades, Mangalam has acquired worldwide reputation as a single stop destination for frontline Anti-malaria. We also have a diversified product range like Anti-retroviral, Anti-Viral, Anti Inflammatory, Rheumatic Arthritis Agent, Uricosuric, Anti– Convulsant, Anti-Hyperliporoteinemic, Anti – Hypertensive and Anti-Bacterial APIs. Mangalam is amongst the top companies in Asia in all the products it makes; and is also the largest manufacturer of some of its products in the world. Along with the WHO-GENEVA GMP Certification and EDQM approval for its API manufacturing plant, the company is also in an agreement with the prestigious Clinton Health Access Initiatives (CHAI) under its Fight Malaria Program for supply of anti-malaria APIs worldwide. |
Product List: 250
PON:Page:
|
| | |
APIs | ACYCLOVIR (ACICLOVIR) [EP/IP]
CAS:59277-89-3
Anti Viral | AMODIAQUINE HCL (USP / IP / IHT)
CAS:6398-98-7
Anti-Malaria | ARTEMETHER (PH.INT. / IP)
CAS:71963-77-4
Anti-Malaria | ARTESUNATE (PH.INT.)
CAS:88495-63-0
Anti-Malaria | ATAZANAVIR SULFATE (PH. INT./ IP /IH)
CAS:229975-97-7
Anti-retroviral | ATORVASTATIN CALCIUM (PH. EUR./IP)
CAS:344423-98-9
Anti hyperlipoproteinemic | BISOPROLOL FUMARATE (PH.EUR. / BP / USP)
CAS:104344-23-2
Antihypertensive | DIHYDROARTEMISININ (PH.INT.)
CAS:71939-50-9
Anti-Malaria | DOLUTEGRAVIR SODIUM (IH)
CAS:1051375-19-9
Antiretroviral activity | EFAVIRENZ (PH. INT. / IP / USP)
CAS:154598-52-4
ANTIRETROVIRAL | EMTRICITABINE (PH. INT. / IP / USP FORUM)
CAS:143491-57-0
ANTIRETROVIRAL | FUROSEMIDE (PH.EUR. / BP / USP / IP)
CAS:54-31-9
Diuretic; Antihypertensive | HYDROXYCHLOROQUINE SULPHATE (PH.EUR. / BP / USP)
CAS:747-36-4
Anti-Malaria | LUMEFANTRINE (PH.INT. / USP )
CAS:82186-77-4
Anti-Malaria | NIMESULIDE (PH.EUR. / BP)
CAS:51803-78-2
Anti-inflammatory | NITROFURANTOIN ANHYDROUS (PH. EUR./USP)
CAS:67-20-9
Anti Bacterial | NITROFURANTOIN MONOHYDRATE (PH. EUR./USP)
CAS:17140-81-7
Anti Bacterial | PIPERAQUINE PHOSPHATE (IHT)
CAS:4085-31-8
Anti-Malaria | PRIMAQUINE PHOSPHATE (PH. EUR. / IP / BP/ USP)
CAS:63-45-6
Anti-Malaria | PYRIMETHAMINE (IH)
CAS:58-14-0
Anti-Malaria | PYRONARIDINE TETRAPHOSPHATE (IHT)
CAS:76748-86-2
Anti-Malaria | SULFADOXINE (IH)
CAS:2447-57-6
Anti-Malaria | TENOFOVIR ALAFENAMIDE HEMIFUMARATE (IH)
CAS:1392275-56-7
Antiretroviral and Hepatitis B | TENOFOVIR DISOPROXIL FUMARATE (PH.INT. / IP)OPEN
CAS:202138-50-9
ANTIRETROVIRAL |
Intermediates | 4,7 DICHLOROQUINOLINE
CAS:86-98-6 | ORTHO PHENOXY METHANE SULFONANILIDE
CAS:51765-51-6 | TENOFOVIR ALAFENAMIDE BASE
CAS:379270-37-8 | TENOFOVIR DISOPROXIL BASE
CAS:201341-05-1 |
Speciality chemical | 2,3-DIHYDROPHTHALAZINE-1,4-DIONE OR PHTHALAZINE-1,4-DIONE
CAS:20116-64-7 | 4-CYNOETHYL-2-METHYL PHENOL
CAS:22516-99-0 | L(+)-MENTHOL
CAS:2216-51-5 | META AMINO ACETANILIDE
CAS:102-28-3 |
Impurities | | |
CAS:Emtricitabine5-epimers(No.n/a) |
CAS:EmtricitabineEnantiomer:no.137530-41-7+ | | ((E)-9-(PROP-1-ENYL)-9H-PURIN-6-AMINE) | (+) –(S)- A-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO[3,2-C]PYRIDINE -5(4H)-ACETIC ACID HYDROCHLORIDE
CAS:144750-42-5 | | ({[(R) -1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY] METHYL} (HYDROXY) PHOSPHORYLOXY) METHYL ISOPROPYL CARBONATE | (1) 2(1H)-PYRIMIDINONE, 4-AMINO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-, (2R-CIS)-; OR
CAS:134678-17-4 | | (2) (-)-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-CYTOSINE. (DES FLUORO EMTRICITABINE) | (2_S_,3_S_)-1,2-EPOXY-3-(BOC-AMINO)-4-PHENYL BUTANE OR (2S,3S)-BOC EPOXY OR BOC-EPOXY DIASTEREOMER IMPURITY
CAS:98737-29-2 | (2R,5R)-5-HYDROXY-1,3-OXATHIOLANE-2-CARBOXYLIC ACID (1R,2S,5R)-5-METHYL-2-(1-METHYLETHYL)CYCLOHEXYL ESTER (HME)
CAS:147126-62-3 | (2R,5S)-(1R,2S,5R)-2-ISO PROPYL-5-METHYLCYCLO HEXYL 5-(4-AMINO-2-OXO PYRIMIDIN-1(2H)-YL)-1,3-OXATHIOLANE-2-CARBOXYLATE (CME)
CAS:147027-10-9 | (2S, 2'S)-DIISOPROPYL 2,2'-((((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHORYL)BIS(AZANEDIYL))DIPROPANOATE OR PMPA BISAMIDATE
CAS:1883563-86-7 | (4-CHLOROPHENYL)(2-ETHYL-1,3-DIOXOLAN-2-YL)ACETONITRILE
CAS:55474-41-4 | (4-CHLOROPHENYL)ACETONITRILE (4-CPA)
CAS:140-53-4 | (4R,12AS)-N-(2-FLUOROBENZYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8, 12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5] PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE OR 4-DES FLUORO DOLUTEGRAVIR
CAS:- | (4R,12AS)-N-(4-FLUOROBENZYL)-7-METHOXY-4-METHYL-6,8-DIOXO-3,4,6,8, 12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5] PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE OR 2-DES FLUORO METHOXY
CAS:- | (4S,12AR)-N-(2,4-DIFLUOROBENZYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6 ,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5] PYRAZINO[2,1-B][1,3] OXAZINE-9-CARBOXAMIDE OR DOLUTEGRAVIR ENANTIOMER (S, R)
CAS:- | | (PS): DIASTEREOMER (PR) | (R)-()-3-(CARBAMOYL METHYL) -5-METHYL HEXANOIC ACID (R-CMH)
CAS:181289-33-8 | (R)-()-3-(CARBAMOYL METHYL)-5-METHYL HEXANOIC ACID OR R-CMH SYSTEM SUITABILITY MIXTURE
CAS:- | | (R)-[1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY] METHYLPHOSPHONIC ACID | (R)-2-AMINO-PROPIONIC ACID ISOPROPYL ESTER OR D-ALANINE ISOPROPYL ESTER HCL
CAS:39613-92-8 | (R)-DIPHENYL (((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONATE
CAS:- | (RS)-1-(4-HYDROXYMETHYLPHENOXY)-3-ISOPROPYLAMINOPROPAN-2-OL
CAS:62572-93-4 | (RS)-1-ISOPROPYLAMINO-3-[4-(2-PROPOXYETHOXYMETHYL)PHENOXY] PROPAN-2-OL
CAS:- | | (RS)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZINE-2(4H)-ONE | (S)-2-((METHOXYCARBONYL)AMINO)-3,3-DIMETHYLBUTANOIC ACID ORMETHOXYCARBONYL-L-TERT-LEUCINE OR MOC-L-TERT-LEUCINE ORATAZANAVIR RELATED COMPOUND A
CAS:162537-11-3 | | (S)-2-(2-AMINO-5-CHLOROPHENYL)-4-CYCLOPROPYL-1,1,1-TRIFLUOROBUT-3YN-2-OL | (S)-2-AMINO-PROPIONIC ACID ISOPROPYL ESTER OR L-ALANINE ISOPROPYL ESTER HCL
CAS:62062-65-1 | (S)-2-AMINOPROPIONIC ACID OR L-A-AMINOPROPIONIC ACID OR L-ALANINE
CAS:56-41-7 | | (S)-ETHYL 4-CHLORO-2-(4-CYCLOPROPYL-1, 1, 1-TRIFLUORO-2-HYDROXYBUT-3-YN-2-YL) PHENYLCARBAMATE | (S)-ISOPROPYL 2-(((S)-((((S)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(PHENOXY)PHOS
CAS:- | | (S)-METHYL 4-CHLORO-2-(4-CYCLOPROPYL-1,1,1-TRIFLUORO-2-HYDROXYBUT-3-YN-2-YL)PHENYL CARBAMATE | +)-3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID (CMH)
CAS:181289-15-6 | [1,3] OXAZINE ACID IMPURITY OR (4R,12AS)-7-METHOXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO [1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXYLIC ACID
CAS:1335210-34-8 | [1,3] OXAZINE AMIDE IMPURITY OR (4R,12AS)-N-(2,4-DIFLUOROBENZYL)-7-METHOXY-4,12A-
CAS:1335210-35-9 | | [2,1-B][1,3]OXAZINE-9-CARBOXAMIDE | [ADENINE] 9H-PURIN-6-AMINE
CAS:73-24-5 | [TENOFOVIR DISOPROXIL CARBAMATE]
CAS:1244022-54-5 | [TENOFOVIR DISOPROXIL ETHYL ESTER]
CAS:- | [TENOFOVIR DISOPROXIL RELATED COMPOUND-B]
CAS:4121-40-8 | [TENOFOVIR ISOPROPYL ISOPROXIL]
CAS:1246812-40-7 | [TENOFOVIR ISOPROXIL MONOESTER]
CAS:211364-69-1 | [TENOFOVIR]
CAS:147127-20-6 | _TERT_-BUTYL 2-(4-(PYRIDIN-2-YL)BENZYL) HYDRAZINECARBOXYLATE (BOC HYDRAZINE)
CAS:198904-85-7 | 1,4-BIS-(4,7-DICHLOROQUINOLINE)PIPERAZINE
CAS:- | 1,4-DIBROMOPENTANE
CAS:626-87-9 | 1-((2R,3R,4R,5R)-3-FLUORO-4-HYDROXY-5-(HYDROXYMETHYL)-3-METHYLTETRA HYDROFURAN-2~YL)PYRIM IDINE-2,4(1H,3H)-DIONE OR SFB URIDINE OR 2’-DEOXY-2’-FLUORO-2’-C-METHYLURIDINE
CAS:817204-32-3 | 1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLANE-5-YL]PYRIMIDINE-2,4-(1H,3H)-DIONE OR LAMIVUDINE URIDINE ANALOGUE
CAS:145986-07-8 | 1-[4-(PYRIDIN-2-YL)PHENYL]-5(S)-2,5-BIS{[N-(METHOXY-CARBONYL)-D-TERT-LEUCINYL]AMINO}-4(R)-HYDROXY-6-PHENYL-2-AZAHEXANE OR ATAZANAVIR DIASTEREOMER R, S, R, R OR (3R,8R,9S,12R)-ATAZANAVIR
CAS:1292296-10-6 | 1-[4-(PYRIDIN-2-YL)PHENYL]-5(S)-2,5-BIS{[N-(METHOXY-CARBONYL)-D-TERT-LEUCINYL]AMINO}-4(S)-HYDROXY-6-PHENYL-2-AZAHEXANE OR ATAZANAVIR DIASTEREOMER R, S, S, R OR (3R,8S,9S,12R)-ATAZANAVIR
CAS:1292296-11-7 | 1-[4-(PYRIDIN-2-YL)PHENYL]-5(S)-2,5-BIS{[N-(METHOXY-CARBONYL)-L-TERT-LEUCINYL]AMINO}-4(R)-HYDROXY-6-PHENYL-2-AZAHEXANE OR ATAZANAVIR DIASTEREOMER S, S, R, S OR 8-EPI ATAZANAVIR
CAS:1292296-09-3 | 1-ETHYL-3-(3-DIMETHYLAMINOPROPYL)CARBODIIMIDE HYDROCHLORIDE (EDC.HCL)
CAS:25952-53-8 | 1-ETHYL-3-(3-DIMETHYLAMINOPROPYL)CARBODIIMIDE (EDC)
CAS:1892-57-5 | 1-METHYLETHYL (2RS)-2-HYDROXY-2-PHENYLACETATE
CAS:4118-51-8 | 1H-BENZO[D][1,2,3]TRIAZOL-1-OL HYDRATE (HOBT MONOHYDRATE)
CAS:123333-53-9 | 2, 3, 4, 5, 6-PENTAFLUOROPHENOLOR PENTAFLUORO PHENOL
CAS:771-69-1 | 2,3-DIHYDROPHTHALAZINE-1,4-DIONE (PRIMAQUINE PHOSPHATE IMPURITY-2: SPECIFIED UNIDENTIFIED IMPURITY; RRT.-0.29)
CAS:1445-69-8 | 2,4 DICHLORO-5-SULPHAMOYL BENZOIC ACID [LASAMIDE]
CAS:2736-23-4 | 2,4-DI DESFLUORO METHOXY IMPURITY OR (4R,12AS)-N-BENZYL-7-HYDROXY-4,12A-DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE
CAS:- | 2,4-DICHLORO BENZOIC ACID (DCBA)
CAS:50-84-0 | 2,4-DICHLOROBENZOIC ACID
CAS:50-84-0 | 2,7-DICHLORO-4-FLUORENYL KETONE
CAS:7012-16-0 | 2-(4-((6-METHOXYQUINOLIN-8-YL)AMINO)PENTYL)ISOINDOLINE-1,3-DIONE SULFATE [ISOINDOLINE-1,3-DIONE]
CAS:- | 2-(4-BROMOPENTYL)ISOINDOLINE 1,3-DIONE OR 4-BROMO-1-PHTHALIMIDO PENTANE (4-BPP)
CAS:59353-62-7 | 2-(4-CHLOROPHENYL)-3-OXOPENTANENITRILE
CAS:55474-40-3 | 2-[[(4RS)-4-[(7-CHLOROQUINOLIN-4-YL)AMINO]PENTYL]-(ETHYL)AMINO]ETHYL HYDROGEN SULFATE OR IMPURITY B
CAS:103152-84-7 | 2-[[2-(ACETYLAMINO)-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL]METHOXY]ETHYL ACETATE OR 9-[(2-ACETOXYETHOXY) METHYL]-N2-ACETYL GUANINE OR DIACETYL ACYCLOVIR OR IMPURITY-G
CAS:75128-73-3 | 2-AMINO-1,7-DIHYDRO-6H-PURINE OR 2-AMINO-9H-PURIN-6 (1H)-ONE OR GUANINE OR IMPURITY-B
CAS:73-40-5 | 2-AMINO-4-CHLORO-5-SULPHAMOYL BENZOIC ACID
CAS:3086-91-7 | 2-CHLORO-1-(2,7-DICHLORO-9H-FLUOREN-4-YL)-ETHANONE
CAS:- | 2-CHLORO-4-[(FURAN-2-YLMETHYL)AMINO]-5-SULPHAMOYL BENZOIC ACID OR
CAS:4818-59-1 | | 2-CHLORO-4-N-FURFURYLAMINO-5-SULFAMOYLBENZOIC ACID | 2-DESFLUORO HYDROXY IMPURITY OR (4R,12AS)-N-(4-FLUOROBENZYL)-7-HYDROXY-4,12A-DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE
CAS:- | 2-DIBUTYLAMINO-1-(2,7-DICHLORO-9H-FLUOREN-4-YL)-ETHANOL
CAS:69759-61-1 | 2-PHENOXYANILINE
CAS:2688-84-8 | 2RS, 5RS)-5-(4-AMINP-2-OXOPYRIMIDINE-1(2H)-YL)-1,3-OXATHIOLANE-2-CARBOXYLICACID OR LAMIVUDINE ACID IMPURITY
CAS:173829-09-9 | 3-AMINO-4-CARBOXAMIDE PYRAZOLE HEMISULFATE (ASP)
CAS:27511-79-1 | 3-MORPHOLOLINO-2-CYANOACRYLAMIDE (MCA)
CAS:25229-97-4 | 4, 6-DICHLORO-5-METHOXY PYRIMIDINE
CAS:5018-38-2 | 4,4’-[PIPERAZINE-1,4-DIYLBIS(PROPANE-3,1-DIYLPIPERAZINE-4,1-DIYL)]BIS(7-CHLOROQUINOLINE).
CAS:86486-21-7 | 4,4’-PIPERAZINE-1,4-DIYLBIS(7-CHLOROQUINOLINE)
CAS:- | 4,5-DICHLOROQUINOLINE
CAS:21617-18-5 | 4,7-DICHLOROQUINOLINE
CAS:86-98-6 | 4,7-DICHLOROQUINOLINE
CAS:86-98-6 | | 4,7-DICHLOROQUINOLINE | 4,7-DICHLOROQUINOLINE
CAS:86-98-6 | 4-(2-PYRIDINYL)BENZALDEHYDE OR PYRIDINYL BENZALDEHYDE
CAS:127406-56-8 | 4-(PYRIDIN-2-YL)BENZOIC ACID OR 4-(2-PYRIDYL)BENZOIC ACIDOR PYRIDINYL BENZOIC ACID
CAS:4385-62-0 | 4-AMINO-5-FLUOROPYRIMIDIN-2(1H)-ONE (FLUORO CYTOSINE)
CAS:2022-85-7 | 4-AMINO-N-(6-CHLORO-5-METHOXYPYRIMIDE-4-YL) BENZENESULFONAMIDE OR 4-AMINO-N-(6-CHLORO-5-METHOXY-4-PYRIMIDINYL) BENZENESULFONAMIDE
CAS:5018-23-5 | 4-AMINOPYRIMIDIN-2(1H)-ONE OR CYTOSINE
CAS:71-30-7 | 4-CHLORO BENZALDEHYDE
CAS:104-88-1 | 4-CHLORO-2-[(6-METHOXYPYRIDIN-3-YL)AMINO]BENZOIC ACID (CMBA)
CAS:- | 4-CHLORO-2-TRIFLUOROACETYL ANILINE HYDROCHLORIDE HYDRATE (KETO ANILINE OR E-2)
CAS:173676-59-0 | 4-CHLORO-5-SULFAMOYLANTHRANILIC ACID
CAS:3086-91-7 | 4-DESFLUORO METHOXY IMPURITY OR (4R,12AS)-N-(2-FLUOROBENZYL)-7-HYDROXY-4,12A-DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE
CAS:1863916-87-3 | 4-DIMETHYL AMINO PYRIDINE OR DIMETHYLAMINO PYIRIDINE
CAS:1122-58-3 | 4-NITRO-2-PHENOXYPHENOL
CAS:70995-08-3 | 4-PIPERAZIN-7-CHLORO-QUINOLINE
CAS:- | 5,6-DIMETHOXYPYRIMIDIN-4-AMINE OR IMPURITY-D
CAS:5018-45-1 | 5-(FORMYLAMINO)-1H-PYRAZOLE-4-CARBOXAMIDE
CAS:22407-20-1 | 5-AMINO-1H-PYRAZOLE-4-CARBOXAMIDE
CAS:5334-31-6 | 5-AMINO-2-METHOXY PYRIDINE (AMP)
CAS:6628-77-9 | 5-CHLORO-4-(4-{3-[4-(7-CHLOROQUINOLIN-4-YL)PIPERAZIN-1-YL] PROPYL}PIPERAZIN-1-YL)QUINOLINE
CAS:918879-09-1 | 5-CHLORO-4-HYDROXY QUINOLINE
CAS:- | 5-FLUORO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL] URACIL (EMTRICITABINE 5-FLUORO URACIL ANALOG)
CAS:145986-11-4 | 6-DESFLUORO BICTEGRAVIR FREE ACID (GS-626446) OR (2R,5S,13AR)-N-(2,4-DIFLUOROBENZYL)-8-HYDROXY-7,9-DIOXO-2,3,4,5, 7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B] [1,3]OXAZEPINE-10-CARBOXAMIDE
CAS:- | 6-METHOXY-8-AMINO QUINOLINE (PRIMAQUINE PHOSPHATE IMPURITY-1: SPECIFIED UNIDENTIFIED IMPURITY; RRT.-0.24)
CAS:90-52-8 | 7,10-DICHLORO-2-METHOXY-5,10-DIHYDROBENZO[B]-1,5-NAPHTHYDINE (DCNM)
CAS:- | 7-CHLORO-4-(4-{3[(7-CHLOROQUINOLIN-4-YL)OXY]PROPYL} PIPERAZIN-1-YL)QUINOLINE
CAS:1233345-93-1 | 7-CHLORO-4-(4-HYDROXY PHENYL AMINO)-QUINOLINE
CAS:- | 7-CHLORO-4-[(2RS)-2-METHYLPYRROLIDIN-1-YL)QUINOLINE OR IMPURITY F
CAS:6281-58-9 | 7-CHLORO-4-[4-(3-CHLOROPROPYL)PIPERAZIN-1-YL]QUINOLINE
CAS:4038-99-7 | 7-CHLORO-4-{4-[3-(PIPERAZIN-1-YL)PROPYL]PIPERAZIN-1-YL}QUINOLINE
CAS:4039-00-3 | 7-CHLORO-4-ETHOXY QUINOLINE
CAS:5448-52-2 | 7-CHLORO-4-PIPERAZINYL QUINOLINE
CAS:837-52-5 | 7-CHLOROQUINOLIN-4-OL
CAS:86-99-7 | A - ARTEMETHER
CAS:71939-51-0 | | ACYCLOVIR* | | ALLOPURINOL | | AMODIAQUINE HYDROCHLORIDE* | | ARTEMETHER*/ARTESUNATE*/DIHYDROARTEMISININ* | ARTEMISININ
CAS:63968-64-9 | | ATAZANAVIR SULFATE* | BENZOIC ACID, 2-HYDROXY-. (SALICYLIC ACID)
CAS:69-72-7 | BICTEGRAVIR AMIDE OR METHYL 1-(2,2-DIMETHOXYETHYL)-3-METHOXY-4-OXO-5-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-1,4-DIHYDROPYRIDINE-2-CARBOXYLATE
CAS:1644158-10-0 | BICTEGRAVIR DIHYDROXY OR METHYL 1-(2,2-DIHYDROXYETHYL)-3-METHOXY-4-OXO-5-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-1,4-DIHYDROPYRIDINE-2-CARBOXYLATE
CAS:- | | BICTEGRAVIR METHOXY OR (2R,5S,13AR)-8-METHOXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE - | | BICTEGRAVIR SODIUM* | BICTEGRAVIR SYSTEM SUITABILITY MIXTURE (BICTEGRAVIR SODIUM AND GS-652240)
CAS:- | BIS ISOINDOLINE-1,3 DIONE IMPURITY OR 2,2'-(PENTANE-1,4-DIYL)BIS(ISOINDOLINE-1,3-DIONE)
CAS:- | BIS((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)DIPHOSPHONIC ACID
CAS:- | | BISOPROLOL FUMARATE* | | BOC-HYDRAZINE OR BOC-HYDRAZINE (N-1 IMPURITY) | CIS-5-[4-AMINO-5-FLUORO-2-OXOPYRIMIDIN-1(2H)-YL]-1,3-OXATHIOLANE-2-CARBOXYLIC ACID (EMTRICITABINE ACID)
CAS:1238210-10-0 | | CLOPIDOGREL BISULPHATE* | DESMETHYL TENOFOVIR DISOPROXIL OR
CAS:365417-53-4 | DIACETAL-3-CARBOXYLIC ACID IMPURITY OR 1-(2,2-DIMETHOXYETHYL)-5-METHOXY-6-(METHOXYCARBONYL)-4-OXO- 1,4-DIHYDROPYRIDINE-3-CARBOXYLIC ACID
CAS:1335210-23-5 | DIHYDROARTEMISININ
CAS:81496-81-3 | | DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO | | DOLUTEGRAVIR SODIUM* | | DOLUTEGRAVIR SODIUM* | EFAVIRENZ AMINO ALCOHOL (EFAVIRENZ AMINO CARBINOL) OR
CAS:209414-27-7 | EFAVIRENZ AMINO ALCOHOL BIS(ETHOXYCARBONYL)OR (S)-ETHYL 4-CHLORO-2-(4-CYCLOPROPYL-2-(ETHOXYCARBONYLOXY)-1, 1, 1-TRIFLUOROBUT-3-YN-2-YL) PHENYLCARBAMATE
CAS:- | EFAVIRENZ AMINO ALCOHOL ETHYL CARBAMATE OR
CAS:- | EFAVIRENZ AMINO ALCOHOL METHYL CARBAMATE OR
CAS:211563-41-6 | EFAVIRENZ BENZOYL AMINO ALCOHOL OR (S)-N-(4-CHLORO-2-(4-CYCLOPROPYL-1, 1, 1-TRIFLUORO-2-HYDROXYBUT-3-YN-2-YL) PHENYL)-4-METHOXY BENZAMIDE
CAS:- | | EFAVIRENZ* | EMTRICITABINE SYSTEM SUITABILITY MIXTURE A (AS PER USP) OR
CAS:Emtricitabine: | | EMTRICITABINE* | ETHYL-(E/Z)-3-(2-CARBETHOXY-2-CYANOETHENYL)-AMINO-1H-PYRAZOLE-4-CARBOXYLATE
CAS:321571-07-7 | ETHYL-5-(FORMYLAMINO)-1H-PYRAZOLE-4-CARBOXYLATE
CAS:31055-19-3 | ETHYL-5-AMINO-1H-PYRAZOLE-4-CARBOXYLATE
CAS:103259-35-4 | | FUROSEMIDE* | | HYDROXYCHLOROQUINE SULPHATE* | ISOPROPYL ((S)-(PERTLUOROPHENOXY)(PHENOXY)PHOSPHORYI)-L-ALANINATE OR SFB-C OR N-[(S)-(2,3,4,5,6-PENTAFLUOROPHENOXY)PHENOXYPHOSPHINYL]-L-ALANINE-1-METHYLETHYL ESTER
CAS:1334513-02-8 | ISOPROPYL ((S)-2-(((2R,3R,4R,5R)-5-(2,4-DIOXO~3 ,4-DLHYDROPYRLMIDIN- 1 (2H)-YL )-4-FLUORO~2-((((S)-(((S)- 1 -I SOPROPOXY-1 -OXOPROPAN-2- YL)AMINO)(PHENOXY) PHOSPHORYL)OXY)METHYL)-4-METHYLTETRAHYDROFURAN- 3-YL)OXY) (PHENOXY)PHOSPHORY1)-L-A1ANINATE OR SFB D
CAS:1337482-17-3 | L-MENTHYL 5-(2R,5S)-[4-AMINO-5-FLUORO-2-OXOPYRIMIDIN-1(2H)-YL]-1,3-OXATHIOLANE-2-CARBOXYLATE (F-CME)
CAS:764659-72-5 | LACTUM IMPURITY OR (4S)-4-(2-METHYLPROPYL)PYRROLIDIN-2-ONE
CAS:61312-87-6 | | LAMIVUDINE* | | LUMEFANTRINE* | MANDELIC ACID IMPURITY OR (2RS)-2-HYDROXY-2-PHENYLACETIC ACID
CAS:90-64-2 | METHYL (+) A-(2-CHLOROPHENYL)-4,5-DIHYDROTHIENO[2,3-C]PYRIDINE -6(7H)-ACETATE. HYDROCHLORIDE
CAS:144750-52-7 | METHYL (-) –(R)-A-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO[3,2-C]PYRIDINE -5(4H)-ACETATE. HYDROGEN SULFATE
CAS:120202-71-3 | MIXTURE OF DIASTEREOMERS OF 4-[(7-CHLOROQUINOLIN-4-YL)AMINO]-N-ETHYL-N-(HYDROXYETHYL) PENTAN-1-AMINE N-OXIDE ORIMPURITY A
CAS:- | MIXTURE OF EMTRICITABINE (5-FLUORO-1-[(2S,5R)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE) + EMTRICITABINE ENANTIOMER (5-FLUORO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE)+ EMTRICITABINE 5-EPIMERS OR EMTRICITABINE DIASTEREOMERS [ENTRIC
CAS:no. 143491-57-0+ | N'-(4-PYRIDIN-2-YL-BENZYLIDENE)-HYDRAZINECARBOXYLIC ACID _TERT_-BUTYL ESTER OR _TERT_-BUTYL [[4-(2-PYRIDINYL)PHENYL]METHYLENE]HYDRAZINECARBOXYLATE OR IMPURITY-A OF
CAS:198904-84-6 | N,N’-(BIS METHYLSULFONYL)-2-PHENOXY ANILINE
CAS:- | N,N’-(BIS METHYLSULFONYL)-2-PHENOXY-4-NITRO ANILINE
CAS:51765-72-1 | N-(2,4-DINITRO-6-PHENOXYPHENYL)-METHANESULPHONAMIDE
CAS:- | N-(2-PHENOXYPHENYL)-METHANESULPHONAMIDE
CAS:51765-51-6 | N-(4-(N-(5,6-DIMETHOXYPYRIMIDIN-4-YL) SULFAMOYL)PHENYL)ACETAMIDE OR IMPURITY-C
CAS:5018-54-2 | N-(4-HYDROXYPHENYL)-ACETAMIDE [PARACETAMOL]
CAS:8/1/8055 | N-(7-CHLOROQUINOLIN-4-YL)-N’-{3-[4-(7-CHLOROQUINOLIN-4-YL) PIPERAZIN-1-YL]PROPYL}ETHANE-1,2-DIAMINE
CAS:- | N-(9-ACETYL-6-OXO-6,9-DIHYDOR-1H-PURIN-2-YL)ACETAMIDE (N2, 9-DIACETYL GUANINE) OR DIACETYL GUANINE OR IMPURITY-L
CAS:3056-33-5 | N-[4-HYDROXY-3,5-BIS(PYRROLIDIN-1-YL METHYL) PHENYL]ACETAMIDE (HPPA)
CAS:- | N-{3-[(DIETHYLAMINO)METHYL]-4-HYDROXYPHENYL}-ACETAMIDE
CAS:- | N-BENZYL EFAVIRENZ OR (S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-1-(4-METHOXYBENZYL)-4-(TRIFLUOROMETHYL)-2H-3,1-BENZOXAZIN-2-ONE
CAS:174819-21-7 | | NIMESULIDE* | | O, O-BIS (ISOPROPOXYCARBONYLOXYMETHYL){(R)-1-[(6-ISOPROPOXYCARBONYL AMINO)-9H-PURIN-9YL] PROPAN-2-YLOXY]}METHYLPHOSPHONATE | | O,O-BIS (ISOPROPYLCARBONYLOXYMETHYL) [(6-AMINO-9H-PURIN-9YL)ETHYLOXY]METHYL PHOSPHONATE | | O-(ETHOXYCARBONYLOXYMETHYL)-O-(ISOPROPOXYCARBONYLOXYMETHYL)-{(R)-[1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY]}METHYLPHOSPHONATE | | O-(ISOPROPOXYCARBONYLOXYMETHYL)-O-ISOPROPYL-{(R)-[1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY]}METHYLPHOSPHONATE | OPEN RING BICTEGRAVIR FREE ACID (GS-649086) OR 9-HYDROXY-2-((1S,3R)-3-HYDROXY CYCLOPENTYL)-1,8-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,8-DIHYDRO-1H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDE
CAS:- | | OR BISPHENYL PMPA | | OR PMPA ANHYDRIDE | P-((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)-N-((S)-1-ISOPROPOX
CAS:- | P-TOLUENE SULFONIC ACID MONOHYDRATE (PTSA) OR 4-METHYLBENZENE SULFONIC ACID
CAS:6192-52-5 | PHENOL OR BENZENOL
CAS:108-95-2 | PHENYL HYDROGEN ((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONATE OR MONOPHENYL PMPA
CAS:379270-35-6 | | PHORYL)AMINO)PROPANOATE OR TAF DIASTEREOMER 1 | | PIPERAQUINE PHOSPHATE* | POTASSIUM PHTHALIMIDE
CAS:1074-82-4 | PREGABALIN ENANTIOMER OR (3R)-3-(AMINO METHYL)-5-METHYLHAXANOIC ACID
CAS:148553-51-9 | PREGABALIN RACEMIC MIXTURE OR 3-(AMINO METHYL)-5-METHYLHAXANOIC ACID
CAS:128013-69-4 | | PREGABALIN* | | PRIMAQUINE PHOSPHATE | | PYRIMETHAMINE* | PYRIMIDINE-2,4-(1H, 3H)-DIONE OR URACIL
CAS:66-22-8 | | PYRONARIDINE TETRAPHOSPHATE* | QUINOLINE ANALOG OR 6-CHLORO-2-CYCLOPROPYL-4-(TRIFLUOROMETHYL)QUINOLINE
CAS:391860-73-4 | RACEMIC MIXTURE (DL) OF METHOXY CARBONYL-L-TERT-LEUCINE OR METHOXY CARBONYL-DL-TERT-LEUCINE
CAS:- | RACEMIC MIXTURE OF (S) 3-AMINO-1-BUTANOL : (R) 3-AMINO-1-BUTANOL
CAS:- | RACEMIC MIXTURE OF DOLUTEGRAVIR [R,S] AND DIASTEREOMER [R,R]
CAS:- | | SOFOSBUVIR* | | SULFADOXINE* | SULFANILAMIDE OR 4-AMINOBENZENESULFONAMIDE
CAS:63-74-1 | TAF (PS): (S)-ISOPROPYL 2-(((S)-((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE : DIASTEREOMER (PR): (S)-ISOPROPYL 2-(((R)-((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)AMINO)PROPANO
CAS:- | | TENOFOVIR ALAFENAMIDE HEMIFUMARATE* | TENOFOVIR ALAFENAMIDE SYSTEM SUITABILITY MIXTURE OR TENOFOVIR ALAFENAMIDE
CAS:- | | TENOFOVIR DISOPROXIL FUMARATE* | TENOFOVIR DISOPROXIL IMPURITY A OR TENOFOVIR RELATED COMPOUND A OR (S)-5-[[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYL]-2,4,6,8-TETRAOXA-5-PHOSPHANONANEDIOIC ACID, BIS (1-METHYLETHYL) ESTER, 5-OXIDE, (E)-2-BUTENEDIOATE (1:1). OR S-ISOMER OF TENOFOVIR
CAS:- | TERT-BUTYL ((S)-1-((R)-OXIRAN-2-YL)-2-PHENYLETHYL)CARBAMATE (BOC EPOXY)
CAS:98760-08-8 | TERT-BUTYL 2-((2S,3S)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTYL) -2-(4-(PYRIDIN-2-YL)BENZYL)HYDRAZINECARBOXYLATE OR DES-N-(METHOXYCARBONYL)-L-TERT-LEUCINE-BIS BOC ATAZANAVIR ORATAZANAVIR DI-TERT-BUTYL ANALOG
CAS:198904-86-8 | USP EFAVIRENZRACEMIC MIXTURE RS OR
CAS:177530-93-7 | | Y-1-OXOPROPAN-2-YL)PHOSPHONAMIDIC ACID OR PMPA MONOAMIDATE |
|
|
|
